U.S., Nov. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07951554) titled 'INTEREST OF CAPA-MEDIUM CULTURE MEDIUM DURING IN VITRO MATURATION FOR THE MANAGEMENT OF POLYCYSTIC OVARY SYNDROME IN ASSISTED REPRODUCTIVE TECHNOLOGY' on Nov. 16.

Brief Summary: The OPKAPAMIV study is a monocentric, open-label clinical trial evaluating the effectiveness of CAPA-MEDIUM culture medium for in vitro maturation (IVM) of oocytes in women with polycystic ovary syndrome (PCOS) undergoing assisted reproductive technology. The primary objective is to achieve a 60% maturation rate of immature cumulus-oocyte complexes (COCs) retrieved from PCOS patients. Secondary objectives include assessing fertilization, blastulation, implan...